Mainstream media commentators love to hand-wring over de-extinction. They look at projects aiming to resurrect the woolly mammoth or the dodo and immediately default to a comfortable, cynical skepticism. They trot out the same tired arguments: it is too expensive, the habitats are gone, the science is sci-fi hubris, and we should focus exclusively on saving living species.
This perspective is fundamentally blind to what is actually happening in the labs.
The critics are treating de-extinction as an expensive zoo-building project. They think Colossal Biosciences is trying to build a real-life Jurassic Park for tourists. They are wrong. De-extinction is not about bringing back the past. It is about building the genetic infrastructure required to save the future. The mammoth is not the goal; it is the stress-test.
The Myth of the Pure Ecosystem
The loudest objection to resurrecting the woolly mammoth ($Mammuthus primigenius$) is that the Pleistocene steppe no longer exists. Cynics ask: where will you put them?
This question assumes that ecosystems are static, immutable museums. They are not. They are dynamic networks driven by keystone species. The loss of megafauna fundamentally degraded the Arctic tundra, turning a highly productive grassland into a moss-dominated, carbon-emitting swamp.
The goal of introducing a cold-tolerant elephant proxy—which is what a "resurrected" mammoth actually is—is to engineer the ecosystem back into balance.
- Trampling snow: Heavy megafauna compress the winter snow blanket, stripping away its insulating properties and allowing the deep Arctic frost to penetrate the permafrost, locking away trillions of tons of greenhouse gases.
- Scraping vegetation: By stripping away moss and knocking down shrubs, these animals encourage the growth of high-albedo grasses that reflect more sunlight back into space.
To say we cannot bring back the mammoth because the habitat is gone is a spectacular display of circular logic. The habitat is gone because the mammoth left.
It Was Never About the Dodo
When companies like Colossal announce they are working on the dodo ($Raphus cucullatus$), the collective eye-roll from traditional conservationists can be heard from space. Why waste millions on a flightless pigeon when thousands of avian species are currently sliding toward oblivion?
This view completely misunderstands how technological translation works in the life sciences.
I have watched biotech ventures burn through hundreds of millions of dollars trying to solve niche genetic diseases, only to discover that the tools they developed along the way revolutionized broad-spectrum oncology. De-extinction is the ultimate catalyst for synthetic biology.
To bring back something resembling a dodo, scientists must pioneer advanced avian reproductive technologies. Right now, editing bird genomes is notoriously difficult due to the structure of the avian egg. You cannot just microinject a single-celled zygote the way you can with a mammal.
By funding the dodo project, investors are paying for the development of:
- Primordial Germ Cell (PGC) isolation: Learning how to culture and edit the precursor cells that become sperm and egg in birds.
- Interspecific chimerism: Perfecting the technique of inserting edited PGCs into a surrogate host (like a chicken) so that it lays eggs containing the genetic material of the target species.
Once you solve these dual engineering bottlenecks for the dodo, you solve them for every endangered bird on the planet. The technology can immediately be deployed to rescue the pink pigeon in Mauritius or the kakapo in New Zealand.
The dodo is simply a high-profile, highly fundable lightning rod that forces the development of platform technologies that traditional conservation grants would never dream of financing.
The False Binary of Funding
Let us dismantle the most economically illiterate argument in the anti-de-extinction playbook: the idea that every dollar spent on genetic resurrection is a dollar stolen from traditional wildlife preserves.
Capital is not a single, monolithic bucket. The venture capital flowing into synthetic biology firms does not come from the same pools of money that fund the World Wildlife Fund or the Nature Conservancy. VC funds operate on a risk-reward mandate looking for intellectual property, scalable platforms, and commercializable spin-offs.
If you ban or defund de-extinction companies, that money does not magically redirect toward building fences around African elephant sanctuaries. It goes right back into SaaS startups, fintech apps, and defense tech.
Furthermore, the technological spin-offs from de-extinction research are directly applicable to human healthcare and agriculture. The multiplex genome editing capabilities being refined to inject thousands of mammoth-specific genetic traits into an Asian elephant ($Elephas maximus$) cell line are the exact same tools required to engineer disease-resistant crops or develop cell therapies for human diseases.
The Hard Truths of the Biotech Approach
A truly honest assessment requires acknowledging the immense friction ahead. We must be brutal about the limitations.
An edited Asian elephant cell line with mammoth traits is still, fundamentally, an Asian elephant cell. Epigenetics—how genes are expressed based on cellular factors that go beyond the raw DNA sequence—presents a massive hurdle. We do not have mammoth cytoplasm. We do not have mammoth gestational environments.
The first generations of these animals will face significant physiological anomalies. There will be developmental failures. Artificial wombs, which are being developed to avoid exploiting living elephant surrogates, are still an unproven technology for large-scale mammalian gestation.
But refusing to attempt the journey because the path is perilous is a luxury we can no longer afford. Traditional conservation is a losing battle of triage. We are merely documenting a decline that we lack the tools to reverse.
Stop Asking "Should We?" and Start Asking "How?"
The debate over whether de-extinction is ethical or practical is thoroughly obsolete. The capital has been raised. The labs are operational. The geneticists are editing. It is happening whether the skeptics approve or not.
Instead of rehashing 1990s movie plots about dinosaurs running amok, regulatory frameworks and conservation bodies need to adapt to reality. We need to establish criteria for how these engineered proxies will be classified under international law. Are they endangered species? Are they modified organisms? How will we manage their introduction into rewilding zones like Pleistocene Park in Siberia?
Stop viewing de-extinction as a nostalgic vanity project. It is the crucible in which the next generation of biodiversity tools is being forged. If we want to preserve a living planet, we have to stop playing defense with the broken tools of the past and start playing offense with the genetic code of the future. Ensure your systems are ready for the influx of engineered biology, because the ecosystem of the next century will be built, not just preserved.
